- Home
- IBG vs XYLO Comparison
IBG vs XYLO Comparison
Compare IBG & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- XYLO
- Stock Information
- Founded
- IBG 2018
- XYLO 1999
- Country
- IBG Australia
- XYLO Israel
- Employees
- IBG N/A
- XYLO N/A
- Industry
- IBG Beverages (Production/Distribution)
- XYLO
- Sector
- IBG Consumer Staples
- XYLO
- Exchange
- IBG Nasdaq
- XYLO NYSE
- Market Cap
- IBG 4.1M
- XYLO 3.8M
- IPO Year
- IBG 2024
- XYLO N/A
- Fundamental
- Price
- IBG $0.54
- XYLO $4.84
- Analyst Decision
- IBG Strong Buy
- XYLO
- Analyst Count
- IBG 1
- XYLO 0
- Target Price
- IBG N/A
- XYLO N/A
- AVG Volume (30 Days)
- IBG 130.1K
- XYLO 1.5K
- Earning Date
- IBG 06-17-2025
- XYLO 06-17-2025
- Dividend Yield
- IBG N/A
- XYLO N/A
- EPS Growth
- IBG N/A
- XYLO N/A
- EPS
- IBG N/A
- XYLO N/A
- Revenue
- IBG $2,931,243.00
- XYLO $29,858,000.00
- Revenue This Year
- IBG N/A
- XYLO $279.19
- Revenue Next Year
- IBG N/A
- XYLO N/A
- P/E Ratio
- IBG N/A
- XYLO N/A
- Revenue Growth
- IBG N/A
- XYLO N/A
- 52 Week Low
- IBG $0.44
- XYLO $2.70
- 52 Week High
- IBG $3.35
- XYLO $6.67
- Technical
- Relative Strength Index (RSI)
- IBG N/A
- XYLO 41.82
- Support Level
- IBG N/A
- XYLO $4.79
- Resistance Level
- IBG N/A
- XYLO $5.26
- Average True Range (ATR)
- IBG 0.00
- XYLO 0.12
- MACD
- IBG 0.00
- XYLO -0.04
- Stochastic Oscillator
- IBG 0.00
- XYLO 10.20
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.